Back to 
ZACKS INVESTMENT MANAGEMENT
ZACKS INVESTMENT MANAGEMENT
ADPT
Showing 0 of 4 quarters
Position history for ZACKS INVESTMENT MANAGEMENT's holdings in ADAPTIVE BIOTECHNOLOGIES COR
No. Zacks Investment Management exited its ADPT (Adaptive Biotechnologies) position in Q2 2023. Its Q1 2023 13F listed 85,627 shares worth $756,085. Zacks Investment Management first reported ADPT in Q3 2022 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.